Skip to main content
Toggle navigation
Search
Home
Conference Program
Tweets by 2023 ASAM Annual Conference
Home
Poster Schedule
All Days
Fri, Apr 14
Sat, Apr 15
Poster Schedule
Type here to filter the list
Friday, April 14, 2023
11:45 AM – 1:15 PM
(1) Healthcare Utilization for Substance Use Disorder related invasive infections
Favorite
11:45 AM – 1:15 PM
(2) Evaluation of an Emergency Resident Curriculum on Medication for Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(3) Impact of a Medication for Opioid Use Disorder Curriculum for Emergency Residents
Favorite
11:45 AM – 1:15 PM
(4) First Responder Experiences with a Novel Naloxone Leave-Behind Program
Favorite
11:45 AM – 1:15 PM
(5) Last Negative: Testing Intervals in People who Inject Drugs with Incident HIV
Favorite
11:45 AM – 1:15 PM
(6) An Integrated Model of HIV Primary Care and Substance Use Treatment
Favorite
11:45 AM – 1:15 PM
(7) Integrating MOUD and HIV PrEP for Adolescents and Young Adults
Favorite
11:45 AM – 1:15 PM
(8) Expanded Methadone Take-Home Use Lowered Methadone-Related Deaths in Black and Hispanic Men
Favorite
11:45 AM – 1:15 PM
(9) Healthcare Experiences of REACH Medical Outreach Patients in Ithaca, NY during COVID-19
Favorite
11:45 AM – 1:15 PM
(10) How Women in Recovery Navigate Pregnancy, Postpartum, and Early Motherhood
Favorite
11:45 AM – 1:15 PM
(11) Missed Opportunities to Support Resilience Among Pregnant People with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(12) Obstetric Clinician Perspectives on the Utility of Toxicology Testing During Pregnancy
Favorite
11:45 AM – 1:15 PM
(13) Survey Assessment of Cannabis Use in an Obstetrics and Gynecology Clinic
Favorite
11:45 AM – 1:15 PM
(14) Drug Testing Interpretation in the Peripartum Setting: Results of Clinician Survey
Favorite
11:45 AM – 1:15 PM
(15) Inpatient Providers’ Attitudes & Clinical Practices surrounding Harm Reduction Services
Favorite
11:45 AM – 1:15 PM
(16) testRI: Communicating Changes in the Rhode Island Local Drug Supply
Favorite
11:45 AM – 1:15 PM
(17) Improving Medical Students' Attitudes toward Addiction through a Stigma Teaching Session
Favorite
11:45 AM – 1:15 PM
(18) Increasing Access to Same-Day Addiction Services in Primary Care Clinics Among Veterans
Favorite
11:45 AM – 1:15 PM
(19) Stimulant Use and Adverse Outcomes in Hospitalized People Using Opioids with Infections
Favorite
11:45 AM – 1:15 PM
(20) Enhancing Future Healthcare Professional Education Surrounding Substance Use Disorders
Favorite
11:45 AM – 1:15 PM
(21) An Initiative to Improve Evidence-Based Nicotine Prescribing in the Primary Care Setting
Favorite
11:45 AM – 1:15 PM
(22) Mind the Gap: Telemedicine Effectively Bridges Patients with OUD to Treatment
Favorite
11:45 AM – 1:15 PM
(23) REDO: Connecting Individuals to Care Post-ED
Favorite
11:45 AM – 1:15 PM
(24) Effects after Self-Administration of Typical Kratom Dose among Regular Kratom-Using Adults
Favorite
11:45 AM – 1:15 PM
(25) Exploring Correlates of Self-Stigma in Persons who use Methamphetamine
Favorite
11:45 AM – 1:15 PM
(26) MiRA1a, a Novel Synthetic THC Analog that Improves Cognition
Favorite
11:45 AM – 1:15 PM
(27) Pharmacological Evaluation of the Ghrelin System as a Target for Binge Drinking
Favorite
11:45 AM – 1:15 PM
(28) Cognitive, Imaging, and Psychiatric Changes Associated with Chronic Toluene Use
Favorite
11:45 AM – 1:15 PM
(29) Major Depressive Disorder Prolongs Hospital Stay Among Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(30) Psychiatric Illness and Intentional Overdose Associated with Suicide Risk in OUD Patients
Favorite
11:45 AM – 1:15 PM
(31) The Past is Never Past: Childhood Trauma Influences Current OUD Severity
Favorite
11:45 AM – 1:15 PM
(32) A Simulation Curriculum to Improve Care of Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(33) Bright Spot Communities: Community-Level Protective Factors to Improve Opioid Outcomes
Favorite
11:45 AM – 1:15 PM
(34) Evaluating the Feasibility and Acceptability of ED-Distributed Fentanyl Test Strips
Favorite
11:45 AM – 1:15 PM
(35) Fentanyl Use in a Pediatric Addiction Clinic – A Retrospective Review
Favorite
11:45 AM – 1:15 PM
(36) Immediate Fentanyl to Extended Release Buprenorphine Transition in Two Adolescents with OUD
Favorite
11:45 AM – 1:15 PM
(37) MOUD Treatment Performance Measures Implemented among Providers in Pennsylvania
Favorite
11:45 AM – 1:15 PM
(38) Opioid and Benzodiazepine Utilization Patterns in Metropolitan and Rural Texas
Favorite
11:45 AM – 1:15 PM
(39) Retention in Telehealth Treatment for Opioid Use Disorder among Rural Populations
Favorite
11:45 AM – 1:15 PM
(40) Race and Mental Health among Adults with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(41) Single Versus Divided Methadone Dosing for Pain Treatment in Persons with OUD
Favorite
11:45 AM – 1:15 PM
(42) A Case of Ocular Buprenorphine Use
Favorite
11:45 AM – 1:15 PM
(43) Development of an Inpatient Protocol for Pain Management of Buprenorphine Patients
Favorite
11:45 AM – 1:15 PM
(44) Pain Management for Patients on Buprenorphine Undergoing Valve Repair Surgery for DUA-IE.
Favorite
11:45 AM – 1:15 PM
(45) Precipitated Withdrawal Refractory to High-Dose Buprenorphine: A Cautionary Tale
Favorite
11:45 AM – 1:15 PM
(46) START: A Program to Spread Buprenorphine Initiation During Hospitalization in Texas
Favorite
11:45 AM – 1:15 PM
(47) Wound Care Uptake among Clients at a Low-Threshold, Mobile Buprenorphine Service
Favorite
11:45 AM – 1:15 PM
(48) Application of the ARIMA Model to Forecast Future Overdose Deaths
Favorite
11:45 AM – 1:15 PM
(49) Bacillus Cereus Panophthalmitis: A Rare Complication of Injection Drug Use
Favorite
11:45 AM – 1:15 PM
(50) Service Utilization in Addiction Treatment across In-Person, Telehealth, and Hybrid Models
Favorite
11:45 AM – 1:15 PM
(51) Social Support in Patients Receiving Buprenorphine Treatment via a Peer-Navigator Program
Favorite
Back to Top
